{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:19:07Z","timestamp":1775719147078,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3718,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1538-7836.2012.04876.x","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:50:24Z","timestamp":1344005424000},"page":"1988-1998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Contemporary management of primary immune thrombocytopenia in adults"],"prefix":"10.1016","volume":"10","author":[{"given":"S.","family":"LAKSHMANAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"CUKER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0010","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0015","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence\u2010based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.hoc.2009.11.004","article-title":"Childhood immune thrombocytopenic purpura: diagnosis and management","volume":"24","author":"Blanchette","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0025","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","article-title":"The incidence of idiopathic thrombocytopenic purpura among adults: a population\u2010based study and literature review","volume":"83","author":"Abrahamson","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0040","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1538-7836.2006.02147.x","article-title":"Prevalence of immune thrombocytopenia: analysis of administrative data","volume":"4","author":"Segal","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2141.2001.02807.x","article-title":"Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study","volume":"113","author":"Foster","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0055","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","article-title":"Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura","volume":"112","author":"Yu","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0060","first-page":"914","article-title":"Type 1 and type 2 T\u2010cell profiles in indiopathic thrombocytopenic purpura","volume":"90","author":"Wang","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2006.06431.x","article-title":"High\u2010level serum B\u2010cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura","volume":"136","author":"Emmerich","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/asheducation.V2010.1.377.3643150","article-title":"Immune thrombocytopenia","volume":"2010","author":"Cuker","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0075","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0080","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","article-title":"Circulating thrombopoietin levels in chronic immune thrombocytopenic purpura","volume":"93","author":"Kosugi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para\u2010apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0095","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0105","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2004-03-0896","article-title":"Anti\u2010GPVI\u2010associated ITP: an acquired platelet disorder causes by autoantibody\u2010mediated clearance of the GPVI\/FcRgamma\u2010chain complex from the human platelet surface","volume":"104","author":"Boylan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T\u2010cell\u2010mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0115","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood-2010-10-312819","article-title":"Long\u2010term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish opulation\u2010based cohort study","volume":"117","author":"N\u00f8rgaard","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0120","first-page":"829","article-title":"Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count","volume":"90","author":"Khellaf","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2007.06635.x","article-title":"The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP","volume":"138","author":"Page","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1185\/03007995.2011.644849","article-title":"Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia","volume":"28","author":"Fogarty","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0028-1086135","article-title":"Management of idiopathic thrombocytopenic purpura in the adult","volume":"3","author":"Lacey","year":"1977","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0140","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","article-title":"Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases","volume":"114","author":"Psaila","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura","volume":"77","author":"Cortelazzo","year":"1991","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0150","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-2362.2007.01855.x","article-title":"Platelet function to estimate the bleeding risk in autoimmune thrombocytopenia","volume":"37","author":"Panzer","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0160","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1538-7836.2011.04506.x","article-title":"Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia","volume":"9","author":"Psaila","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0165","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1185\/03007990802377461","article-title":"Health\u2010related quality of life of immune thrombocytopenic purpura patients: results from a web\u2010based survey","volume":"24","author":"Snyder","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajh.20992","article-title":"Self\u2010reported health\u2010related quality of life in adults with chronic immune thrombocytopenic purpura","volume":"83","author":"McMillan","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","article-title":"Propsective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antiplatelet antibodies","volume":"76","author":"Aledort","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2010.08418.x","article-title":"Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population\u2010based cohort study","volume":"152","author":"Severinsen","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0190","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case\u2010control study in Sweden","volume":"42","author":"S\u00f6derberg","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0195","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population\u2010based case\u2010control study in Scandanavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0200","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population\u2010based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0210","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1371\/journal.pmed.0030024","article-title":"Long\u2010term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia","volume":"3","author":"Stasi","year":"2006","journal-title":"PLos Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0220","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.hoc.2009.08.008","article-title":"Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet function","volume":"23","author":"McMillan","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.1997.d01-2064.x","article-title":"International study to compare antigen\u2010specific methods used for the measurement of antiplatelet autoantibodies","volume":"96","author":"Berchtold","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0230","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0235","first-page":"1041","article-title":"The course of severe autoimmune thrombocytopenia in patients not undergoing splenectomy","volume":"91","author":"Sailer","year":"2006","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0240","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00277-002-0488-x","article-title":"Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinicial features and response to therapy","volume":"81","author":"Pamuk","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0245","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2003-11-3908","article-title":"Long\u2010term outcomes in adults with chronic ITP after splenectomy failure","volume":"104","author":"McMillan","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0250","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJMoa030254","article-title":"Initial treatment of immune thrombocytopenic purpura with high\u2010dose dexamethasone","volume":"349","author":"Cheng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0255","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2005-12-015222","article-title":"Therapy with high\u2010dose dexamethasone (HD\u2010DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience","volume":"109","author":"Mazzucconi","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0260","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.3687.3687","article-title":"High dose dexamethasone vs. conventional dose prednisolone for adults with immune thrombocytopenia: a prospective multicenter phase III trial [abstract]","volume":"116","author":"Bae","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0265","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","article-title":"Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia","volume":"115","author":"Zaja","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0270","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/blood-2011-08-374777","article-title":"A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia","volume":"119","author":"Arnold","year":"2012","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0275","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1182\/blood-2006-03-004481","article-title":"A closer look at intravascular hemolysis (IVH) following intravenous anti\u2010D for immune thrombocytopenic purpura (ITP)","volume":"109","author":"Tarantino","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0280","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1182\/blood-2004-03-1168","article-title":"Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long\u2010term platelet count responses, prediction of response, and surgical complications","volume":"104","author":"Kojouri","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0285","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10253","article-title":"Long term follow\u2010up after splenectomy performed for immune thrombocytopenic purpura (ITP)","volume":"72","author":"Schwartz","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/asheducation-2010.1.385","article-title":"Evidence\u2010based mini\u2010review: is indium\u2010labeled autologous platelet scanning predictive of response to splenectomy in patients with chronic immune thrombocytopenia?","volume":"2010","author":"Cuker","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0295","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/0003-4819-151-8-200910200-00008","article-title":"Risk for hospital contact with infection in patients with splenectomy: a population\u2010based cohort study","volume":"151","author":"Thomsen","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2011.08843.x","article-title":"Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato\u2010Oncology task force","volume":"155","author":"Davies","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0305","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","article-title":"Vascular complications after splenectomy for hematologic disorders","volume":"114","author":"Crary","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0310","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2141.2012.09146.x","article-title":"Short\u2010 and long\u2010term risks of splenectomy for benign haematological disorders: should we revisit the indications?","volume":"158","author":"Rodeghiero","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","article-title":"Systematic review: efficacy and safety of rituximab for adults with chronic idiopathic thrombocytopenic purpura","volume":"146","author":"Arnold","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0320","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-11-393975","article-title":"Outcome at 5\u2003years following response to rituximab therapy in children and adults with immune thrombocytopenia (ITP)","volume":"119","author":"Patel","year":"2012","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2010.01486.x","article-title":"Low\u2010dose rituximab in adult patients with primary immune thrombocytopenia","volume":"85","author":"Zaja","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0330","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ajh.21512","article-title":"Repeated courses of rituximab in chronic ITP: three different regimens","volume":"84","author":"Hasan","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0335","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV\u2010negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0345","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","article-title":"Safety and efficacy of long\u2010term treatment with romiplostim in thrombocytopenic patients with chronic ITP","volume":"113","author":"Bussel","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0350","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB\u2010497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson\u2010Miller","year":"2009","journal-title":"Stem Cells"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double\u2010blind randomized controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0360","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1002625","article-title":"Romiplostim or standard of care in patients with immune thrombocytopenia","volume":"363","author":"Kuter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0365","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(10)60959-2","article-title":"Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6\u2010month, randomized, phase 3 study","volume":"377","author":"Cheng","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0370","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.68.68","article-title":"Long\u2010term efficacy and safety of romiplostim treatment of adult patients with chronic immune thrombocytopenia (ITP): final report from an open\u2010label extension study [abstract]","volume":"116","author":"Kuter","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0375","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.3296.3296","article-title":"Safety and efficacy of extended treatment with eltrombopag in adults with chronic immune thrombocytopenia (ITP) from June 2006 to February 2011 [abstract]","volume":"118","author":"Saleh","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0380","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2008.07464.x","article-title":"Improved quality of life for romiplostim\u2010treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo\u2010controlled trials","volume":"144","author":"George","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0385","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double\u2010blind, placebo\u2010controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0390","first-page":"CD008235","article-title":"TPO receptor agonist for chronic idiopathic thrombocytopenic purpura","author":"Zeng","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0395","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/157488610790936196","article-title":"Safety of the thrombopoiesis\u2010stimulating agents for the treatment of immune thrombocytopenia","volume":"5","author":"Cuker","year":"2010","journal-title":"Curr Drug Saf"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0400","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.528.528","article-title":"Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenic purpura (ITP) treated with eltrombopag \u2013 data from the EXTEND study [abstract]","volume":"118","author":"Brynes","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0405","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2009-05-224766","article-title":"Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim","volume":"114","author":"Kuter","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0410","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.seminhematol.2010.03.002","article-title":"Toxicities of the thrombopoietic growth factors","volume":"47","author":"Cuker","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0415","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.V116.21.70.70","article-title":"Incidence of thromboembolic events across eltrombopag clinical trials in chronic immune thrombocytopenia (ITP) [abstract]","volume":"116","author":"Bussel","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0420","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1538-7836.2010.03830.x","article-title":"Evaluation of bleeding and thrombotic events during long\u2010term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)","volume":"8","author":"Gernsheimer","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0425","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood.V118.21.1164.1164","article-title":"Rate of cataracts across the eltrombopag clinical studies in patients with chronic immune thrombocytopenia [abstract]","volume":"118","author":"Cooper","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0430","first-page":"47","article-title":"Orphan disease gains second treatment option","volume":"18","author":"Morrow","year":"2009","journal-title":"Manag Care"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2012.04876.x_bb0435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3310\/hta13suppl2-09","article-title":"Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal","volume":"13","author":"Mowatt","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0440","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/11591550-000000000-00000","article-title":"Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a nice single technology appraisal","volume":"30","author":"Boyers","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0445","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9343(99)80342-8","article-title":"Long\u2010term observation of 208 adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"1995","journal-title":"Am J Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0450","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.21109","article-title":"Is splenectomy still the gold standard for the treatment of chronic ITP?","volume":"83","author":"Rodeghiero","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-140-3-200402030-00012","article-title":"Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review","volume":"140","author":"Vesely","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood-2009-06-222448","article-title":"Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura","volume":"115","author":"Arnold","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0465","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1182\/blood-2007-01-065763","article-title":"Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP)","volume":"110","author":"Boruchov","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0470","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","article-title":"How I treat idiopathic thrombocytopenic purpura (ITP)","volume":"106","author":"Cines","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0037-1963(00)90106-9","article-title":"Management of idiopathic thrombocytopenic purpura in pregnancy","volume":"37","author":"Gill","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0480","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/asheducation-2010.1.397","article-title":"Thrombocytopenia in pregnancy","volume":"2010","author":"McCrae","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0485","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood-2002-10-3317","article-title":"A retrospective 11\u2010year analysis of obstetric patients with idiopathic thrombocytopenic purpura","volume":"102","author":"Webert","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0490","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1365-2141.2003.04567.x","article-title":"Intravenous anti\u2010D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy","volume":"123","author":"Michel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0495","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199007263230404","article-title":"Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura","volume":"323","author":"Samuels","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0505","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(90)92430-P","article-title":"Fetal platelet counts in thrombocytopenic pregnancy","volume":"336","author":"Kaplan","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2012.04876.x_bb0510","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00006254-199312000-00003","article-title":"Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery","volume":"48","author":"Burrows","year":"1993","journal-title":"Obstet Gynecol Surv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04876.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622064960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04876.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:57:02Z","timestamp":1761533822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622064960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1538783622064960"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04876.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary management of primary immune thrombocytopenia in adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04876.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}